We are thrilled to share that Ms. Jennifer Che, our President and Managing Director, has been recognized in IAM Strategy 300 Global Leaders 2026. This follows our recent announcement recognizing Ms. Che in the list of IAM Global Leaders 2026, which focuses on patent prosecution.

IAM Strategy 300 showcases the top strategy experts in the IP world. It is the “only resource of its kind, acknowledging leaders from across in-house, private practice and service provider roles”. A slot in the 300 is the “mark of a professional whose approach to intellectual property is regarded by peers as truly strategic in nature.”

IAM's comprehensive research process involved gathering nominations and insights from thousands of sources over a five month period, leading to in-depth interviews with selected candidates.

Jennifer's inclusion in this elite group is a testament to her ability to inspire and innovate, continually providing exceptional value to our clients and setting a benchmark in the industry.


Please join us in congratulating Jennifer on this well-deserved recognition. Her expertise and dedication to her work make her an invaluable asset to our team and our clients.

我們過去活動

Recommended Insights

China Top 10 Patent Re-Examination and Invalidation Cases of 2020 CNIPA Upholds Bayer’s Rivaroxaban Patent

2021年6月9日
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]

RNAi Patent Success in China: Overcoming “Comprising” Claim Challenges

2025年3月10日
An Update on Sufficiency and Inventiveness of RNAi Patents in China RNAi is a fast-developing technology that has gained traction in the pharmaceutical industry as a promising therapeutic agent. It is important to follow closely RNAi patent proceedings to learn how different examination boards and courts understand and handle these new technologies. The first-ever invalidation […]

SPC Upholds $2M RMB Award in China’s First Patent Case on a Biological Deposit

2022年7月4日
On 28 Feb 2022, China’s Supreme People’s Court (SPC) issued its annual “Judgment Digests”, which includes a list of “48 typical cases” highlighting representative SPC decisions in 2021. The Judgment Digests help us understand more about the SPC’s judicial ideology, trial concepts, and adjudication methods in dealing with difficult and sophisticated legal issues as well […]

Stealing Trade Secrets: How the Chinese Court Criminally Sentences Employees that Steal Trade Secrets - 2019 China’s Top 50 Representative IP Cases

2020年6月11日
The theft of trade secrets has always been a deep concern of foreign companies thinking of doing business in China, whether it be sharing protocols with a manufacturing partner, providing technology details to a potential investor, or sharing results from an R&D collaboration. How can businesses ensure that employees do not steal secrets and share […]
Top crossarrow-right